You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS status (wild type, mutant)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial (Tislelizumab, Irinotecan Hydrochloride, cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Mar 23, 2023

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Vectibix With Chemotherapy for Metastatic Colorectal Cancer

Completed
Has Results
  • Wild-type RAS Metastatic Colorectal Cancer
  • Panitumumab + Chemotherapy
  • (no location specified)
Nov 4, 2022

Colorectal Cancer Trial in Hangzhou (Ametumumab, Anti-PD-1 mAb, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
Jan 30, 2023

New Prognostic Score for Adult RAS Wild-type mCRC Treated With

Active, not recruiting
  • Metastatic Colorectal Cancer
  • RAS Wild-type
  • Freiburg, Baden-Württemberg, Germany
    Praxis für interdisziplinäre Onkologie & Hämatologie
Jul 29, 2022

Metastatic Breast Cancer Trial (Estradiol)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Feb 6, 2023

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

Recruiting
  • Metastatic Colorectal Cancer
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
  • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
  • Avignon, France
  • +5 more
Aug 2, 2022

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

Active, not recruiting
  • Treatment Related Cancer
  • Munich, Germany
    Ludwig Maximilians University
Jan 19, 2022

Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)

Recruiting
  • Neoadjuvant Treatment
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Apr 15, 2022

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Cancer of Colon Trial in Jerusalem (Cetuximab)

Terminated
  • Cancer of Colon
  • Jerusalem, Israel
    Hadassah Ein Kerem
Aug 2, 2022

Metastatic Colorectal Cancer. Real-World Data Analysis.

Completed
  • Metastatic Colorectal Cancer
    • Istanbul, Turkey
      Istanbul Medeniyet University Hospital
    Oct 25, 2021

    Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

    Not yet recruiting
    • Malignant Solid Neoplasm
    • +4 more
    • (no location specified)
    Nov 8, 2022